CD274 and neoplasm: Treating 4T1 tumor-bearing mice with BMS-202 NPs resulted in a significant decrease in 4T1 tumor growth, which was identical to the antitumor effect induced by anti-PD-L1 monoclonal antibody (α-PD-L1) treatment.